Asi, Thelma T.
HRN: 14-77-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2025
CEFTRIAXONE 1G (VIAL)
09/14/2025
09/21/2025
IV
2G
OD
TYPHOID
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines